In addition, UCB and HO-1 simultaneously reduce the increasing tumor necrosis factor-α (TNF-α), nitric oxide (NO), iNOS, endothelial dysfunction, and they block proliferation and migration of the cells via Raf/ERK/MAPK pathway and display anti-inflammatory activity as well. The gene discussed is TNF; the disease is endothelial dysfunction.